|
|
||||||||
The Journal of Immunology, Vol 134, Issue 3 1516-1523, Copyright © 1985 by American Association of Immunologists
ARTICLES |
AW Boyd, KC Anderson, AS Freedman, DC Fisher, B Slaughenhoupt, SF Schlossman and LM Nadler
Investigation of the activation of splenic B cells by anti- immunoglobulin (Ig) antibody has enabled us to characterize the anti-Ig- responsive B cell and to analyze the phenotypic changes which accompany proliferation and differentiation. The anti-Ig antibody-responsive B cell population was characterized by the expression of high levels of the B2 antigen and represented approximately 40% of splenic B cells. Brisk mitogenesis which peaked at 3 to 4 days was induced by anti-Ig antibody. The proliferative phase was characterized phenotypically by a dramatic decline in B2 antigen expression, with most cells showing no detectable B2 by 4 days post-activation. The other hallmark of this phase was de novo expression of a group of "activation antigens." These included the B cell-restricted antigens B-LAST 1, BB1, and B5, and the T cell-associated interleukin 2 receptor and T12 antigens. Concomitantly, B1, B4, and Ia expression increased, the increase being roughly proportional to the increase in cell size. After day 4, the mitogenic response progressively diminished, while Ig synthesis increased. During this differentiation phase, cell surface antigens again displayed a distinct sequence of changes. The five activation antigens and the B1, B4, and Ia antigens began to decrease. However, two markers, T10 and PCA-1, which are found on plasmacytomas, appeared and their level of expression steadily increased. These changes and the appearance of morphologically identifiable plasma cells required the presence of T cells in this system. T cell supernatants alone induced Ig secretion but did not induce expression of PCA-1 or the appearance of cells with plasma cell morphology. The culture system developed in this study has allowed us to analyze the antigenic changes following activation by anti-Ig antibody. This sequence of changes has not only permitted the identification of antigens which, by their appearance at distinct stages may have an important role in proliferation and differentiation of B cells, but also provides us with the means of studying the function of each antigen.
This article has been cited by other articles:
![]() |
S. Hassler, C. Ramsey, M. C. Karlsson, D. Larsson, B. Herrmann, B. Rozell, M. Backheden, L. Peltonen, O. Kampe, and O. Winqvist Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma Blood, September 15, 2006; 108(6): 1941 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Amano, E. Amano, T. Moll, D. Marinkovic, N. Ibnou-Zekri, E. Martinez-Soria, I. Semac, T. Wirth, L. Nitschke, and S. Izui The Yaa Mutation Promoting Murine Lupus Causes Defective Development of Marginal Zone B Cells J. Immunol., March 1, 2003; 170(5): 2293 - 2301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tolnay, L. A. Vereshchagina, and G. C. Tsokos NF-{kappa}B Regulates the Expression of the Human Complement Receptor 2 Gene J. Immunol., December 1, 2002; 169(11): 6236 - 6243. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Vereshchagina, M. Tolnay, and G. C. Tsokos Multiple Transcription Factors Regulate the Inducible Expression of the Human Complement Receptor 2 Promoter J. Immunol., May 15, 2001; 166(10): 6156 - 6163. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Depraetere, L. Verhoye, G. Leclercq, and G. Leroux-Roels Human B Cell Growth and Differentiation in the Spleen of Immunodeficient Mice J. Immunol., March 1, 2001; 166(5): 2929 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sato, M. Hasegawa, M. Fujimoto, T. F. Tedder, and K. Takehara Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity J. Immunol., December 1, 2000; 165(11): 6635 - 6643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Freedman, J. Munro, G. Rice, M. Bevilacqua, C Morimoto, B. McIntyre, K Rhynhart, J. Pober, and L. Nadler Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110 Science, August 31, 1990; 249(4972): 1030 - 1033. [Abstract] [PDF] |
||||
![]() |
R. Hardy, K Hayakawa, M Shimizu, K Yamasaki, and T Kishimoto Rheumatoid factor secretion from human Leu-1+ B cells Science, April 3, 1987; 236(4797): 81 - 83. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |